AnalystsMike MatsonMike Matson's Stock Forecasts
AnalystsMike Matson
Analyst Ranking
Top 11%
#573 out of 5205 analysts
Average Return
+3.32%
Win Rate
45%224 out of 496
Risk vs Reward
Poor
Good
Mike Matson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Personalis IncPSNL | +426.23% | $1.22 | $6.42 | 2024-06-20 - 2025-06-20 | Buy |
Personalis IncPSNL | +269.23% | $1.17 | $4.32 | 2023-11-07 - 2024-11-07 | Buy |
Personalis IncPSNL | +212.73% | $1.65 | $5.16 | 2024-05-08 - 2025-05-08 | Buy |
Personalis IncPSNL | +210.28% | $2.14 | $6.64 | 2024-01-04 - 2025-01-03 | Buy |
Personalis IncPSNL | +198.02% | $3.03 | $9.03 | 2025-04-09 - 2026-02-26 | Buy |
Mike Matson Analyst Color
Get additional color on Mike Matson's coverage of popular stocks
Mike Matson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Veracyte IncVCYT | 19 | Buy | $48.00 | +23.87% | Maintains | 2 days ago |
Livanova PLCLIVN | 28 | Buy | $81.00 | +14.08% | Maintains | 3 days ago |
Merit Medical Systems IncMMSI | 33 | Buy | $101.00 | +29.45% | Maintains | 3 days ago |
Transmedics Group IncTMDX | 7 | Buy | $174.00 | +29.30% | Maintains | 3 days ago |
Establishment Labs Holdings IncESTA | 6 | Buy | $86.00 | +11.47% | Maintains | 4 days ago |
Medtronic PLCMDT | 9 | Buy | $120.00 | +23.67% | Maintains | 11 days ago |
Neogenomics IncNEO | 28 | Buy | $15.00 | +47.49% | Maintains | 11 days ago |
Atricure IncATRC | 32 | Buy | $45.00 | +42.23% | Reiterates | 16 days ago |
Boston Scientific CorpBSX | 29 | Buy | $97.00 | +28.05% | Maintains | 23 days ago |
Artivion IncAORT | 26 | Buy | $58.00 | +52.31% | Reiterates | a month ago |
Stryker CorpSYK | 10 | Buy | $454.00 | +17.60% | Maintains | a month ago |
Teleflex IncTFX | 5 | Buy | $138.00 | +15.95% | Upgrades | a month ago |
Penumbra IncPEN | 7 | Buy | $388.00 | +13.47% | Maintains | 2 months ago |
Lucid Diagnostics IncLUCD | 22 | Buy | $3.00 | +104.08% | Reiterates | 3 months ago |
Insight Molecular Diagnostics IncIMDX | 20 | Buy | $9.00 | +58.73% | Maintains | 4 months ago |
Haemonetics CorpHAE | 13 | Buy | $78.00 | +25.32% | Maintains | 4 months ago |
Personalis IncPSNL | 21 | Buy | $10.00 | +10.74% | Maintains | 4 months ago |
Orthopediatrics CorpKIDS | 21 | Buy | $26.00 | +46.15% | Maintains | 4 months ago |
Enovis CorpENOV | 16 | Buy | $49.00 | +92.76% | Maintains | 7 months ago |
Conmed CorpCNMD | 24 | Hold | $61.00 | +32.98% | Downgrades | 9 months ago |
Inogen IncINGN | 8 | Buy | $12.00 | +86.34% | Upgrades | 9 months ago |
Hologic IncHOLX | 15 | Hold | $90.00 | N/A | Downgrades | a year ago |
Paragon 28 IncFNA | 16 | Hold | $13.00 | N/A | Downgrades | a year ago |
Resmed IncRMD | 10 | Hold | $236.00 | N/A | Downgrades | a year ago |
Surmodics IncSRDX | 14 | Buy | $43.00 | N/A | Maintains | 2 years ago |
Inari Medical IncNARI | 4 | Buy | $57.00 | N/A | Maintains | 2 years ago |
Shockwave Medical IncSWAV | 6 | Buy | $286.00 | N/A | Maintains | 2 years ago |
Masimo CorpMASI | 12 | Buy | $86.00 | N/A | Maintains | 2 years ago |
Axonics IncAXNX | 15 | Buy | $63.00 | N/A | Maintains | 2 years ago |
Inmode LtdINMD | 8 | Buy | $60.00 | N/A | Reiterates | 3 years ago |
Steris PLCSTE | 6 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zimmer Biomet Holdings IncZBH | 15 | Hold | N/A | N/A | Downgrades | 4 years ago |
Cardiovascular Systems IncCSII | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Invacare CorpIVCRQ | 1 | Buy | $8.00 | N/A | Maintains | 4 years ago |
Genmark Diagnostics IncGNMK | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Si Bone IncSIBN | 1 | Buy | $34.00 | N/A | Maintains | 5 years ago |
Globus Medical IncGMED | 1 | Buy | $75.00 | N/A | Maintains | 5 years ago |
Cantel Medical CorpCMD | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Hill Rom Holdings IncHRC | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Nuvasive IncNUVA | 1 | Buy | $74.00 | N/A | Upgrades | 6 years ago |
Wright Medical Group NvWMGI | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.